SCHEMBL23947819

SCHEMBL23947819

c1ccc(-c2ccc3c(c2)c2cccc(-c4ccc5oc6ccc(-c7nc(-c8ccccc8)nc(-c8cccc9c8oc8ccccc89)n7)cc6c5c4)c2n3-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.39
PIM1 P11309 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
PRKDC P78527 2/20 0.33
GGPS1 O95749 1/20 0.33
MAPT P10636 4/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
KDM4E B2RXH2 2/20 0.32
TSHR P16473 2/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22541760 0.96 PIM1 (0.36) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL23947553 0.95 ALOX5 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL21192048 0.94 ALOX5 (0.39) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL22541740 0.94 ALOX5 (0.37) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL23947314 0.94 ALOX5 (0.41) ALOX5PRKDCGGPS1MAPTSIRT2
SCHEMBL22541765 0.94 ALOX5 (0.40) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL23947466 0.94 PLA2G2A (0.36) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL22541780 0.94 PLA2G2A (0.36) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL22541721 0.94 PLA2G2A (0.36) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL23947514 0.94 ALOX5 (0.38) ALOX5PIM1CSNK2A2CSNK2BPIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, UBE2L3, OPRL1 ALOX5 2287/4885PIM1 2441/4885CSNK2A2 228/4885
US-11873297-B2 Compound and organic light emitting device comprising the same CCNL2, UBE2L3, ARL1 ALOX5 2234/4885PIM1 3128/4885CSNK2A2 208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.